{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(4)"],"submitter":["Momotow J"],"funding":["Bristol-Myers Squibb","Meso Scale Diagnostics","Novartis"],"journal":["HemaSphere"],"pagination":["e293"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6919467"],"repository":["biostudies-literature"],"pubmed_title":["Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center."],"pmcid":["PMC6919467"],"funding_grant_id":["NCT02181738"],"pubmed_authors":["Tresckow BV","Goergen H","Brockelmann PJ","Behringer K","Engert A","Momotow J","Borchmann S","Kobe C","Sasse S"],"additional_accession":[]},"is_claimable":false,"name":"Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Oct","modification":"2026-05-07T02:08:43.051Z","creation":"2025-04-05T15:36:01.225Z"},"accession":"S-EPMC6919467","cross_references":{"pubmed":["31942546"],"doi":["10.1097/HS9.0000000000000293"]}}